Showing results (111-120 of 183) with videos related to

Sort By:
Pageof 19
Neuro-Oncology|October 15, 2021
IDH wild-type grade 2 diffuse astrocytomas: prognostic factors and impact of treatments within molecular subgroupsRoberta Rudà, Francesco Bruno, Tamara Ius, et al.
Journal of Neuro-Oncology|June 1, 2023
Association between thyroid function and regorafenib efficacy in patients with relapsed wild-type IDH glioblastoma: a large multicenter studyMario Caccese, Isacco Desideri, Marta Padovan, et al.
Neuro-Oncology|September 12, 2023
Brain tumor-related epilepsy management: A Society for Neuro-oncology (SNO) consensus review on current managementEdward K Avila, Steven Tobochnik, Sara K Inati, et al.
Neuro-Oncology|August 12, 2025
STAT3 expression in brain metastases from breast cancer is correlated with molecular subtype and impacts clinical outcomeAlessia Pellerino, Neibla Priego, Luca Bertero, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|July 15, 2026
Impact of BRAF inhibitors on surgical outcomes in melanoma brain metastases: Evidence from a multicenter observational studyDaniele Armocida, Andrea Bianconi, Francesco Carbone, et al.
World Neurosurgery|February 25, 2019
Lower Grade Gliomas: Relationships Between Metabolic and Structural Imaging with Grading and Molecular FactorsMarco Riva, Egesta Lopci, Antonella Castellano, et al.
Neuro-Oncology|September 11, 2015
Kinetics of tumor size and peritumoral brain edema before, during, and after systemic therapy in recurrent WHO grade II or III meningiomaJulia Furtner, Veronika Schöpf, Katharina Seystahl, et al.
Neuro-Oncology|January 1, 2017
Leptomeningeal metastases: a RANO proposal for response criteriaMarc Chamberlain, Larry Junck, Dieta Brandsma, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|July 13, 2020
Medulloblastoma of the adult: results from a multicenter retrospective study by AINO (Italian Association of Neuro-Oncology) and SIN (Italian Society of Neurology)Paola Gaviani, Giorgia Simonetti, Roberta Rudà, et al.
Anticancer Research|October 3, 2018
Different Timing to Use Bevacizumab in Patients with Recurrent Glioblastoma: Early Versus Delayed AdministrationFrancesco Pasqualetti, Alessandra Gonnelli, Alessandro Molinari, et al.
Pageof 19